MBCs were categorized as Luminal-like in nearly all cases (33% as Luminal A, 57.8% as Luminal B HER2-, and 4.6% as Luminal B HER2-positive, respectively), with one case of HER2-positive BC and four cases of triple-negative BC. Here, ERBB2 is linked to breast cancer.